SGTX
Geode Capital Management’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-96,499
| Closed | -$89.8K | – | 4837 |
|
|
2023
Q1 | $89.8K | Sell |
96,499
-26,300
| -21% | -$24.5K | ﹤0.01% | 4382 |
|
|
2022
Q4 | $42K | Buy |
122,799
+420
| +0.3% | +$144 | ﹤0.01% | 4640 |
|
|
2022
Q3 | $61K | Buy |
122,379
+1,134
| +0.9% | +$565 | ﹤0.01% | 4721 |
|
|
2022
Q2 | $100K | Sell |
121,245
-125,932
| -51% | -$104K | ﹤0.01% | 4595 |
|
|
2022
Q1 | $363K | Buy |
247,177
+13,024
| +6% | +$19.1K | ﹤0.01% | 4107 |
|
|
2021
Q4 | $646K | Buy |
234,153
+2,491
| +1% | +$6.87K | ﹤0.01% | 3919 |
|
|
2021
Q3 | $1.31M | Buy |
231,662
+97,887
| +73% | +$553K | ﹤0.01% | 3546 |
|
|
2021
Q2 | $1.44M | Buy |
133,775
+11,835
| +10% | +$127K | ﹤0.01% | 3425 |
|
|
2021
Q1 | $2.73M | Buy |
121,940
+105,011
| +620% | +$2.35M | ﹤0.01% | 3109 |
|
|
2020
Q4 | $813K | Buy |
+16,929
| New | +$813K | ﹤0.01% | 3425 |
|